Phase I Study of the Anti-interleukin 33 Fragment Antigen-Binding Region RO7303359 in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Veeral Sheth (ORCID: https://orcid.org/0000-0002-7467-9947)
- Jeffrey R. Willis (ORCID: https://orcid.org/0000-0002-6712-1144)
- Flávia Brunstein
- Arshad M. Khanani (ORCID: https://orcid.org/0000-0001-8928-5599)
- Vahan B Indjeian
- Denison Kuruvilla (ORCID: https://orcid.org/0000-0003-4547-9572)
- Joel Pearlman (ORCID: https://orcid.org/0000-0002-2295-7538)
- Randall Dere (ORCID: https://orcid.org/0000-0003-4120-7828)
- Maurício Maia (ORCID: https://orcid.org/0000-0002-7034-8091)
- Hao Chen (ORCID: https://orcid.org/0009-0001-6480-7976)
- Ling Ma (ORCID: https://orcid.org/0000-0001-8760-3581)
- Seema Datta
- Henry E. Wiley
Institutions
- University of Nevada, Reno (US)
- University of Illinois Chicago (US)
- California Retina Consultants (US)
- Illinois Retina Associates (US)
- Sierra Eye Associates (US)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-04-20
- DOI
- https://doi.org/10.1016/j.xops.2025.100800
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Genentech